Immunology and Microbiology
Immune-Mediated Inflammatory Diseases
100%
COVID-19
62%
Immunosuppressive Therapy
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Immunosuppressive Drug
50%
Vaccine Efficacy
50%
Inflammatory Bowel Disease
37%
Hidradenitis Suppurativa
25%
Inflammatory Arthritis
25%
Vaccination Policy
18%
Rituximab
12%
Tumor Necrosis Factor
12%
Arthropathy
6%
Immunosuppressant
6%
Medicine and Dentistry
Inflammatory Disorder
50%
Immunosuppressive Treatment
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
mRNA Vaccine
50%
Immunosuppressive Drug
50%
Cohort Analysis
50%
Infection
37%
Immunosuppressant
31%
Corticosteroid
12%
Inflammatory Bowel Disease
12%
Tumor Necrosis
12%
COVID-19
12%
Rituximab
12%
Psoriasis
6%
Vaccine
6%
Arthropathy
6%
COVID-19 Vaccination
6%
COVID-19 Vaccine
6%
Proportional Hazards Model
6%
Pharmacology, Toxicology and Pharmaceutical Science
mRNA Vaccine
50%
Inflammatory Disease
50%
Cohort Study
50%
Immunosuppressive Agent
50%
SARS Coronavirus
50%
Infection
20%
Vaccination Policy
10%
Rituximab
6%
Inflammatory Bowel Disease
6%
Tumor Necrosis
6%
Corticosteroid
6%